MGNX – macrogenics, inc. (US:NASDAQ)
Stock Stats
News
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at StockNews.com from a "sell" rating to a "buy" rating.
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
MacroGenics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
MacroGenics to Participate in Upcoming Investor Conferences
MacroGenics, Inc. (NASDAQ: MGNX) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Form SC 13G/A MACROGENICS INC Filed by: BlackRock, Inc.
Form 8-K MACROGENICS INC For: Nov 05
Form 10-Q MACROGENICS INC For: Sep 30
Form 8-K MACROGENICS INC For: Oct 25
Form SC 13G/A MACROGENICS INC Filed by: BlackRock, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.